can you switch between semaglutide and tirzepatide Switching weight-loss medications How to Stop Taking Tirzepatide:

UK Chief Medical Officers advise keeping alcohol consumption to no more than 14 units per week, spread over three or more days, with several alcohol-free days each week

Dosing fundamentals Administration: Once weekly subcutaneous injection Same day each week (consistency matters) Preferably at the same time of day Half-life: Approximately 6 days, supporting weekly dosing Dose escalation: Every 4 weeks, unless: Side effects require holding current dose Individual tolerance suggests faster/slower progression Healthcare provider recommends adjustment Clinical trial doses tested The Phase 2 obesity trial tested multiple dosing arms: Key insight: 8 mg produces nearly the same results as 12 mg with fewer side effectsmaking it a potential "sweet spot" for many users

In: Luster, et al., editors

This guide explains what Retatrutide actually is, what the published trial data shows, how the triple mechanism works, where it stands in terms of availability and legal status in Thailand, the side effects and monitoring it demands, and why a physician-guided, clinical-grade approach matters more here than almost anywhere else